Literature DB >> 18395252

TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas.

Caroline Thielen1, Vincent Radermacher, Mounir Trimeche, Florence Roufosse, Michel Goldman, Jacques Boniver, Laurence de Leval.   

Abstract

The current study attempts to characterize the eosinophilia associated with T-cell lymphomas and to investigate its possible relationship with the secretion of eosinophil-stimulating factors by lymphoma cells and/or intra-tumoral surrounding cells. Paraffin-embedded specimens from 50 patients diagnosed with peripheral T-cell lymphomas, either unspecified (PTCL-U, n=30) or angioimmunoblastic (AITL, n=20) were morphologically assessed for intra-tumoral eosinophilia and analyzed by immunohistochemistry using specific antibodies directed against TARC, IL-5, RANTES, and eotaxin. The AITL and PTCL-U cases contained a mean of 147+/-41 and 102+/-37 eosinophils per 10 high power fields, respectively. Thirty-two of 47 cases (68%) showed IL-5-positive lymphoma cells while 15/50 (30%) tumors showed variable staining for TARC in scattered non-lymphoid cells with dendritic morphology. TARC and IL-5-positive cases possessed significantly more eosinophils. Our data indicate that IL-5 and TARC expression highly correlate with eosinophilia in T-cell lymphomas, suggesting that these chemokines are involved in the recruitment of eosinophils into the tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395252     DOI: 10.1016/j.leukres.2008.02.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T.

Authors:  Douglas G McNeel; Thomas A Gardner; Celestia S Higano; Philip W Kantoff; Eric J Small; Mark H Wener; Robert B Sims; Todd DeVries; Nadeem A Sheikh; Robert Dreicer
Journal:  Cancer Immunol Res       Date:  2014-09-04       Impact factor: 11.151

2.  Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.

Authors:  Jianhua Zhou; Ning Kang; Lianxian Cui; Denian Ba; Wei He
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

3.  Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell.

Authors:  Li-Bing Liu; Feng Xie; Kai-Kai Chang; Wen-Qing Shang; Yu-Han Meng; Jia-Jun Yu; Hui Li; Qian Sun; Min-Min Yuan; Li-Ping Jin; Da-Jin Li; Ming-Qing Li
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

4.  New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2008-09       Impact factor: 0.196

Review 5.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?

Authors:  Julien Catherine; Florence Roufosse
Journal:  Semin Immunopathol       Date:  2021-05-19       Impact factor: 9.623

6.  Xiao-Qing-Long-Tang shows preventive effect of asthma in an allergic asthma mouse model through neurotrophin regulation.

Authors:  Ren-Shiu Chang; Shulhn-Der Wang; Yu-Chin Wang; Li-Jen Lin; Shung-Te Kao; Jiu-Yao Wang
Journal:  BMC Complement Altern Med       Date:  2013-09-08       Impact factor: 3.659

7.  Diagnosis of primary pulmonary T- cell/histiocyte-rich large B cell lymphoma with tissue eosinophilia via clinicopathological observation and molecular assay.

Authors:  Jin Zhu; Yingmei Wang; Li Gong; Gaosheng Huang
Journal:  Diagn Pathol       Date:  2014-10-02       Impact factor: 2.644

8.  Angioimmunoblastic T-Cell Lymphoma: A Questionable Association with Follicular Dendritic Cell Sarcoma.

Authors:  Daniel Benharroch; Miriam Zekzer; Karen Nalbandyan
Journal:  Case Rep Hematol       Date:  2017-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.